Dvorak H, Cohen S, Ward P
Inflammation. 2013; 1(2):127-41.
PMID: 24194423
DOI: 10.1007/BF00917524.
Ota K, Quint P, Weivoda M, Ruan M, Pederson L, Westendorf J
Bone. 2013; 57(1):68-75.
PMID: 23891907
PMC: 3845829.
DOI: 10.1016/j.bone.2013.07.023.
Kubota M, Yoshida T, Shinomiya K, MIKAWA H
Clin Exp Immunol. 1980; 40(3):602-10.
PMID: 7418268
PMC: 1538950.
Immunology. 1982; 47(1):169-74.
PMID: 7118158
PMC: 1555505.
Donabedian H, Gallin J
J Clin Invest. 1982; 69(5):1155-63.
PMID: 7068851
PMC: 370180.
DOI: 10.1172/jci110551.
Inflammatory synovial tissue mononuclear cells release leucocyte migration inhibition factor in antigen- and mitogen-free cultures.
Egeland T, Mellbye O, Pahle J
Ann Rheum Dis. 1981; 40(4):388-95.
PMID: 7020614
PMC: 1000734.
DOI: 10.1136/ard.40.4.388.
An in vitro assay for uni-directional migration inhibition employing 51Cr-labelled macrophages.
Huang S
Clin Exp Immunol. 1980; 40(3):627-32.
PMID: 6998620
PMC: 1538953.
Human monocyte-derived chemotactic factor for granulocytes.
Nakayama M, Matsumoto S
Immunology. 1980; 39(4):607-13.
PMID: 6991401
PMC: 1458019.
Rosette-increasing factor (RIF) generated in vivo following PHA skin test.
Kubota M, MIKAWA H
Clin Exp Immunol. 1981; 44(2):315-23.
PMID: 6975675
PMC: 1537358.
Purification of a lymphoid cell line product with leukocyte inhibitory factor activity.
Meshulam D, Blair H, Wong B, Charm S, Minowada J, Rocklin R
Proc Natl Acad Sci U S A. 1982; 79(2):601-5.
PMID: 6952211
PMC: 345793.
DOI: 10.1073/pnas.79.2.601.
Cell-mediated immunity to myoglobin in polymyositis.
Herrera-Esparza R, Magana L, Moreno J, Fraga A, Lavalle C
Ann Rheum Dis. 1983; 42(2):182-6.
PMID: 6847263
PMC: 1001096.
DOI: 10.1136/ard.42.2.182.
A chemotactic inhibitor in synovial fluid.
Matzner Y, Partridge R, Babior B
Immunology. 1983; 49(1):131-8.
PMID: 6840801
PMC: 1454083.
Studies on the mechanism of PMN activation III. by lymphokines.
Muller J, Botzenhardt U, Lemmel E
Blut. 1983; 46(3):155-9.
PMID: 6824796
DOI: 10.1007/BF00320274.
Leucocyte migration inhibition response to tissue antigens in asymptomatic individuals infected with Trypanosoma cruzi.
Peralta J, Gill K, Cordeiro Lima M, Coura J
Clin Exp Immunol. 1981; 45(3):621-6.
PMID: 6802533
PMC: 1537406.
Cellular, molecular, and genetic characteristics of T cell reactivity to collagen in man.
Solinger A, Bhatnagar R, Stobo J
Proc Natl Acad Sci U S A. 1981; 78(6):3877-81.
PMID: 6791165
PMC: 319676.
DOI: 10.1073/pnas.78.6.3877.
The regulation of tissue eosinophil chemotactic factor and inhibitor in allergic skin lesions of Freund's complete adjuvant-treated guinea-pigs.
Hirashima M, Tashiro K, Hayashi H
Immunology. 1984; 51(3):441-50.
PMID: 6365742
PMC: 1454466.
Two inhibitors of neutrophil chemotaxis are produced by hyperimmunoglobulin E recurrent infection syndrome mononuclear cells exposed to heat-killed staphylococci.
Donabedian H, Gallin J
Infect Immun. 1983; 40(3):1030-7.
PMID: 6343237
PMC: 348154.
DOI: 10.1128/iai.40.3.1030-1037.1983.
Effects of leukocyte inhibitory factor (LIF) on human neutrophil function.
Klempner M, Rocklin R
Inflammation. 1983; 7(2):145-53.
PMID: 6305834
DOI: 10.1007/BF00917819.
Neutrophil response to LIF: lack of glucocorticoid effect despite enhanced chemokinesis.
Lurie D, DeLustro F, LeRoy E
Inflammation. 1983; 7(1):49-56.
PMID: 6301986
DOI: 10.1007/BF00918007.
Cellular immunity in congestive cardiomyopathy. The normal cellular immune response.
Lowry P, Thompson R, Littler W
Br Heart J. 1985; 53(4):394-9.
PMID: 3157395
PMC: 481779.
DOI: 10.1136/hrt.53.4.394.
